Certican 0.25mg Tablet contains Everolimus, an advanced immunosuppressant medicine used to prevent organ transplant rejection, especially after kidney or heart transplantation.

 It works by suppressing the immune system’s overactivity, helping the body accept the transplanted organ and prevent rejection.

In addition, Certican is also used to treat certain cancers and tumors, including renal cell carcinoma, breast cancer, and neuroendocrine tumors, by blocking abnormal cell growth and reducing cancer progression.

Key Benefits:

Prevents rejection after organ transplantation

Helps the body accept kidney or heart transplants

Controls immune response and prevents inflammation

Effective in treating specific types of cancers and tumors

Supports long-term transplant survival and health

Uses:

Prevention of organ transplant rejection (kidney or heart)

Treatment of certain cancers (renal cell carcinoma, breast cancer, neuroendocrine tumors)

Management of abnormal immune activity (as prescribed)

Dosage:

The dosage depends on blood levels, body weight, and medical condition.

Usually taken once or twice daily at the same time every day.

Swallow the tablet whole with water, with or without food.

Regular blood tests are required to monitor Everolimus levels.

Safety Information:

Avoid contact with individuals who have infections, as Certican lowers immunity.

Not recommended during pregnancy or breastfeeding unless prescribed.

Inform your doctor if you have liver or kidney problems.

Store below 25°C in a cool, dry place.

Keep out of reach of children.